Generic Plavix is used for reducing the risk of stroke or heart attack in patients who have already had a heart attack or stroke or have other circulatory problems due to narrowing and hardening of the arteries. More info »
Dr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US market - Economic Times
CBS NewsDr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US marketEconomic TimesMUMBAI: Pharma major Dr Reddy's Laboratories and Nasdaq listed- Mylan Inc today announced launching of Clopidogrel tablets, USP, a bioequivalent generic version of Plavix in the US market.
Dr. Reddy's Announces the Launch of Clopidogrel Tablets, USP - EON: Enhanced Online News (press release)
Dr.
Aurobindo Pharma receives final approval for Clopidogrel Tablets - Equity Bulls
Aurobindo Pharma receives final approval for Clopidogrel TabletsEquity BullsAurobindo Pharma LImited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75 mg (ANDA 090540), which is being launched.
FDA Approves Generic Versions of Plavix - Everyday Health
FDA Approves Generic Versions of PlavixEveryday HealthBy Steven Reinberg, HealthDay Reporter THURSDAY, May 17, 2012 (HealthDay News) — The US Food and Drug Administration on Thursday approved generic versions of the blood thinner Plavix (clopidogrel), making the widely used medication more affordable for .
FDA Approves Generic Versions of Plavix - Health.com